Skip to main content
Glow Lifetech logo

Glow Lifetech — Investor Relations & Filings

Ticker · GLOW ISIN · CA37989H1091 LEI · 5493000039SP09BBAI87 CSE Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2025-07-15 Regulatory Filings
Country CA Canada
Listing CSE GLOW

About Glow Lifetech

https://glowlifetech.com/

Glow Lifetech is a biotechnology company specializing in ingredient innovation for the nutraceutical and cannabinoid markets. The company supplies cutting-edge, natural active ingredients for functional foods, beverages, supplements, and personal care products. Its core technology is the proprietary MyCell® delivery system, which converts proprietary cannabinoids, vitamins, and botanicals into highly bioavailable, water-soluble liquid formats. This system is engineered to optimize absorption, ensuring dramatically improved bioavailability, faster onset (in as little as 20 minutes), enhanced stability, and a clean, neutral taste profile. Glow offers solutions ranging from foundational water-soluble ingredients and customized blends to fully market-ready products, serving as an innovation partner for companies seeking to launch and scale next-generation natural health products.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release providing an operational and commercial update (commissioning of a new bottling line and product launch). It does not present financial results (so not ER or IR), is not a formal regulatory report (10-K, IR, AR, etc.), nor does it announce governance changes, M&A, dividends, or share issues. No specific filing category applies, making it a general regulatory/news announcement. Therefore, it falls into the fallback “Regulatory Filings” category (RNS).
2025-07-15 English
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 1% confidence The document is an amendment to a private property option agreement between an individual and a mining company, not an earnings release, management report, or regulatory form. It outlines contractual terms and share-issuance conditions. This does not fit specialized categories like M&A, share issuance notice, or AGM materials. It is best classified as a general regulatory filing fallback (RNS).
2025-06-19 English
Notice of the meeting and record date - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal “Notice of Meeting and Record Date” for an upcoming Annual and Special Meeting of securityholders. It outlines the meeting date, record date for voting, class of securities entitled to vote, and other proxy logistics—key elements of the proxy solicitation process. This notice is preparatory to sending proxy materials and fits squarely within “Proxy Solicitation & Information Statement” filings, which cover materials sent to shareholders (or filed with regulators) to provide information and request votes for meetings. Therefore, the correct classification is PSI.
2025-06-19 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” from the CFO, certifying that the interim financial report and MD&A for the period ended March 31, 2025 have been reviewed and contain no material misstatements. It is not the interim report itself but a statutory certification under NI 52-109, so it does not fit categories like IR (Interim Report) or MDA (Management Discussion & Analysis). It is a standalone regulatory compliance filing, falling into the fallback “Regulatory Filings” category (RNS).
2025-05-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 certification of interim filings under Canadian NI 52-109, providing the CEO’s certificate on the interim financial report and MD&A. It does not contain the reports themselves nor financial data, investor presentation, or voting results; rather, it is a regulatory compliance filing. It does not fit any specific category like Interim Report, MD&A, or Audit Report. Therefore it falls under the fallback category for miscellaneous regulatory filings.
2025-05-30 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three months ended March 31, 2025 and 2024” and contains narrative explanations of quarterly financial performance, forward-looking statements, strategic outlook, and non-IFRS measures. It is not a full annual report, audit report, or regulatory notice but a standalone MD&A for a quarterly period. This falls under Management Reports (Code: MDA).
2025-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.